Azithromycin therapy for prevention of chronic lung disease of prematurity (AZTEC): a randomised placebo-controlled trial
This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16/111/106.
Authors
- Sinéad Ahearn-Ford (ORCID: https://orcid.org/0000-0001-5979-9636)
- Julian Roberto Marchesi (ORCID: https://orcid.org/0000-0002-7994-5239)
- Marie Hubbard (ORCID: https://orcid.org/0000-0003-0388-4983)
- Mandy Lau (ORCID: https://orcid.org/0000-0001-5894-570X)
- Janet Elizabeth Berrington (ORCID: https://orcid.org/0000-0002-6185-2843)
- Claudia Consoli
- Ali F. Aboklaish (ORCID: https://orcid.org/0000-0002-6426-8757)
- Professor Kerenza Hood
- Mark Goddard
- C J Stewart
- Sailesh Kotecha
- John Lowe
- Mark Turner
- David Gillespie
- Malavika Babu
- Greg Young
Institutions
- University of Liverpool (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Liverpool Women's Hospital (GB)
- University College London (GB)
- Imperial College London (GB)
- Cardiff University (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Health Technology Assessment
- Published
- 2025-04-01
- DOI
- https://doi.org/10.3310/gjsk0401
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Imperial College London
- University of Oxford
- Trinity College Dublin